Skip to main content
. 2018 Jul 19;11(2):485–496. doi: 10.1016/j.stemcr.2018.06.012

Figure 3.

Figure 3

Derivation of New hESC Lines (2008–2016)

(A) Number of hESC lines that were reported for the first time in original research papers during the time periods indicated.

(B) Percentage of disease-specific (light blue) and clinical-grade (dark blue) hESC lines in total new cell lines reported in original research papers during the time periods indicated.